These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9849485)

  • 21. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations.
    Nonnenmacher B; Kruger Kjaer S; Svare EI; Scott JD; Hubbert NL; van den Brule AJ; Kirnbauer R; Walboomers JM; Lowy DR; Schiller JT
    Int J Cancer; 1996 Dec; 68(6):704-9. PubMed ID: 8980170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time trends in the prevalence of human papillomavirus infections in archival Papanicolaou smears: analysis by cytology, DNA hybridization, and polymerase chain reaction.
    Rakoczy P; Sterrett G; Kulski J; Whitaker D; Hutchinson L; MacKenzie J; Pixley E
    J Med Virol; 1990 Sep; 32(1):10-7. PubMed ID: 2173733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of human papillomavirus in Papanicolaou smears: correlation with pathologic findings and clinical outcome.
    Nuovo GJ
    Diagn Mol Pathol; 1998 Jun; 7(3):158-63. PubMed ID: 9836071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer.
    Walboomers JM; de Roda Husman AM; Snijders PJ; Stel HV; Risse EK; Helmerhorst TJ; Voorhorst FJ; Meijer CJ
    J Clin Pathol; 1995 Aug; 48(8):728-32. PubMed ID: 7560199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
    Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
    Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history of cervicovaginal papillomavirus infection in young women.
    Ho GY; Bierman R; Beardsley L; Chang CJ; Burk RD
    N Engl J Med; 1998 Feb; 338(7):423-8. PubMed ID: 9459645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears.
    Jacobs MV; Zielinski D; Meijer CJ; Pol RP; Voorhorst FJ; de Schipper FA; Runsink AP; Snijders PJ; Walboomers JM
    Br J Cancer; 2000 Apr; 82(8):1421-6. PubMed ID: 10780521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
    JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Estimation of HPV infection presence in cytological smears in a group of asymptomatic women].
    Łukaszuk K; Liss J; Zalewski J; Roter M; Brzóska B; Debniak J
    Wiad Lek; 2001; 54(9-10):508-15. PubMed ID: 11816294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefits and costs of using HPV testing to screen for cervical cancer.
    Mandelblatt JS; Lawrence WF; Womack SM; Jacobson D; Yi B; Hwang YT; Gold K; Barter J; Shah K
    JAMA; 2002 May; 287(18):2372-81. PubMed ID: 11988058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.
    Zielinski GD; Snijders PJ; Rozendaal L; Voorhorst FJ; van der Linden HC; Runsink AP; de Schipper FA; Meijer CJ
    Br J Cancer; 2001 Aug; 85(3):398-404. PubMed ID: 11487272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.
    Arora R; Kumar A; Prusty BK; Kailash U; Batra S; Das BC
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):104-9. PubMed ID: 15950365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of human papillomavirus infection by dry vaginal swabs in military women.
    Shah KV; Daniel RW; Tennant MK; Shah N; McKee KT; Gaydos CA; Gaydos JC; Rompalo A
    Sex Transm Infect; 2001 Aug; 77(4):260-4. PubMed ID: 11463925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
    Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
    JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomaviruses in Amerindian women from Brazilian Amazonia.
    Brito EB; Martins SJ; Menezes RC
    Epidemiol Infect; 2002 Jun; 128(3):485-9. PubMed ID: 12113494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group.
    Sellors JW; Mahony JB; Kaczorowski J; Lytwyn A; Bangura H; Chong S; Lorincz A; Dalby DM; Janjusevic V; Keller JL
    CMAJ; 2000 Sep; 163(5):503-8. PubMed ID: 11006760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
    Salmerón J; Lazcano-Ponce E; Lorincz A; Hernández M; Hernández P; Leyva A; Uribe M; Manzanares H; Antunez A; Carmona E; Ronnett BM; Sherman ME; Bishai D; Ferris D; Flores Y; Yunes E; Shah KV
    Cancer Causes Control; 2003 Aug; 14(6):505-12. PubMed ID: 12948281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPV testing in primary screening of older women.
    Cuzick J; Beverley E; Ho L; Terry G; Sapper H; Mielzynska I; Lorincz A; Chan WK; Krausz T; Soutter P
    Br J Cancer; 1999 Oct; 81(3):554-8. PubMed ID: 10507785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal Papanicolaou smear. A population-based study of risk factors in Greenlandic and Danish women.
    Kjaer SK; Poll P; Jensen H; Engholm G; Haugaard BJ; Teisen C; Christensen RB; Möller KA; Vestergaard BF; de Villiers EM
    Acta Obstet Gynecol Scand; 1990; 69(1):79-86. PubMed ID: 2161172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.